Mechanisms of Ramipril Reduction in the Onset of Type 2 Diabetes

This study has been terminated.
(Lack of funding)
King Pharmaceuticals is now a wholly owned subsidiary of Pfizer
Information provided by (Responsible Party):
Stephen N. Davis, University of Maryland Identifier:
First received: December 13, 2007
Last updated: December 1, 2014
Last verified: December 2014
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2014
  Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)